Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zara Sheikh, Hui Xin Ong, Michele Pozzoli, Paul M Young & Daniela Traini. (2018) Is there a role for inhaled anti-inflammatory drugs in cystic fibrosis treatment?. Expert Opinion on Orphan Drugs 6:1, pages 69-84.
Read now
Read now
Articles from other publishers (19)
Bo Wang, Jia Xiang, Binsheng He, Songwen Tan & Wenhu Zhou. (2023) Enhancing bioavailability of natural extracts for nutritional applications through dry powder inhalers (DPI) spray drying: technological advancements and future directions. Frontiers in Nutrition 10.
Crossref
Crossref
Erennur Tufan, Selman Kesici & Benan Bayrakci. 2023. Humidification in the Intensive Care Unit. Humidification in the Intensive Care Unit
271
277
.
Jack Wellmerling, Rachael E. Rayner, Sheng‐Wei Chang, Elizabeth L. Kairis, Sun Hee Kim, Amit Sharma, Prosper N. Boyaka & Estelle Cormet‐Boyaka. (2022) Targeting the EGFR‐ERK axis using the compatible solute ectoine to stabilize CFTR mutant F508del. The FASEB Journal 36:5.
Crossref
Crossref
Zara Sheikh, Peta Bradbury, Tristan A. Reekie, Michele Pozzoli, Paul D. Robinson, Michael Kassiou, Paul M. Young, Hui Xin Ong & Daniela Traini. (2021) Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line. European Journal of Pharmacology 902, pages 174098.
Crossref
Crossref
Joaquim Calvo-Lerma, Mieke Boon, Jessie Hulst, Carla Colombo, Inês Asseiceira, María Garriga, Etna Masip, Ine Claes, Anna Bulfamante, Hettie M. Janssens, Maria Roca, Saioa Vicente, Victoria Fornés, Laura Zazzeron, Bo van Schijndel, Sandra Woodcock, Luisa Pereira, Kris de Boeck & Carmen Ribes-Koninckx. (2021) Change in Nutrient and Dietary Intake in European Children with Cystic Fibrosis after a 6-Month Intervention with a Self-Management mHealth Tool. Nutrients 13:6, pages 1801.
Crossref
Crossref
Hamed Sheykhloo, Morteza MilaniFarhood NajafiFarhad Bani & Amir Zarebkohan. (2020)
Conjugation of Gentamicin to Polyamidoamine Dendrimers Improved Anti-bacterial Properties against
Pseudomonas aeruginosa
. Advanced Pharmaceutical Bulletin 11:4, pages 675-683.
Crossref
Crossref
Nermeen A. ElKasabgy, Islam M. Adel & Mohamed F. Elmeligy. (2020) Respiratory Tract: Structure and Attractions for Drug Delivery Using Dry Powder Inhalers. AAPS PharmSciTech 21:7.
Crossref
Crossref
Yuan-Chieh Yeh, Tse-Hung Huang, Shih-Chun Yang, Chin-Chang Chen & Jia-You Fang. (2020) Nano-Based Drug Delivery or Targeting to Eradicate Bacteria for Infection Mitigation: A Review of Recent Advances. Frontiers in Chemistry 8.
Crossref
Crossref
Rachel Gaul, Joanne M. Ramsey, Andreas Heise, Sally-Ann Cryan & Catherine M. Greene. 2018. Design of Nanostructures for Versatile Therapeutic Applications. Design of Nanostructures for Versatile Therapeutic Applications
221
253
.
Bob A. Lubamba. (2017) XBP1 et réponse inflammatoire des macrophages alvéolaires au cours de la mucoviscidose. médecine/sciences 33:4, pages 380-382.
Crossref
Crossref
Cheryl Stewart & Michael S. Pepper. (2015) Cystic fibrosis on the African continent. Genetics in Medicine 18:7, pages 653-662.
Crossref
Crossref
Anna Diana, Angela Maria Polizzi, Teresa Santostasi, Luigi Ratclif, Maria Giuseppina Pantaleo, Giuseppina Leonetti, Danila Rosa Iusco, Crescenzio Gallo, Massimo Conese & Antonio Manca. (2016) The novel complex allele [A238V;F508del] of the CFTR gene: clinical phenotype and possible implications for cystic fibrosis etiological therapies. Journal of Human Genetics 61:6, pages 473-481.
Crossref
Crossref
Laurent Meijer, Deborah J. Nelson, Vladimir Riazanski, Aida G. Gabdoulkhakova, Geneviève Hery-Arnaud, Rozenn Le Berre, Nadège Loaëc, Nassima Oumata, Hervé Galons, Emmanuel Nowak, Laetitia Gueganton, Guillaume Dorothée, Michaela Prochazkova, Bradford Hall, Ashok B. Kulkarni, Robert D. Gray, Adriano G. Rossi, Véronique Witko-Sarsat, Caroline Norez, Frédéric Becq, Denis Ravel, Dominique Mottier & Gilles Rault. (2016) Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis. Journal of Innate Immunity 8:4, pages 330-349.
Crossref
Crossref
Carsten Schwarz. (2015) Colobreathe? for the Treatment of Cystic Fibrosis-Associated Pulmonary Infections. Pulmonary Therapy 1:1, pages 19-30.
Crossref
Crossref
Ivana d’Angelo, Bruno Casciaro, Agnese Miro, Fabiana Quaglia, Maria Luisa Mangoni & Francesca Ungaro. (2015) Overcoming barriers in Pseudomonas aeruginosa lung infections: Engineered nanoparticles for local delivery of a cationic antimicrobial peptide. Colloids and Surfaces B: Biointerfaces 135, pages 717-725.
Crossref
Crossref
Yonjung Kim, Marc O. Anderson, Jinhong Park, Min Goo Lee, Wan Namkung & A. S. Verkman. (2015)
Benzopyrimido-pyrrolo-oxazine-dione (
R
)-BPO-27 Inhibits CFTR Chloride Channel Gating by Competition with ATP
. Molecular Pharmacology 88:4, pages 689-696.
Crossref
Crossref
Carsten Schwarz & Dominik Hartl. (2015) Cystic fibrosis in Europe: patients live longer but are we ready?. European Respiratory Journal 46:1, pages 11-12.
Crossref
Crossref
Mark R. Cookson. (2015) LRRK2 Pathways Leading to Neurodegeneration. Current Neurology and Neuroscience Reports 15:7.
Crossref
Crossref
Guido VeitRadu G. AvramescuDoranda PerdomoPuay-Wah PhuanMiklos BagdanyPirjo M. ApajaFlorence BorotDaniel SzollosiYu-Sheng WuWalter E. FinkbeinerTamas HegedusAlan S. VerkmanGergely L. Lukacs. (2014) Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression. Science Translational Medicine 6:246.
Crossref
Crossref